- Registration Date 2017-03-09
- Hit 10728
Company Information |
|
1. Name |
Biosolution Co., Ltd. |
2. Website Address |
http://www.biosolutions.co.kr |
3. Location |
5F, Seoul Technopark, 232, Gongneung-ro, Nowon-gu, Seoul 01811, Korea |
4. Contacts |
TEL : +82-2-3446-8884 FAX : +82-2-3445-1380 Email : dvmljs@biosolutions.co.kr |
Pharmaceutical Product Information |
|
1. Brand Name |
KeraHeal® |
2. Active Ingredient |
Autologous skin-derived keratinocytes |
3. Indication |
1. Deep 2nd degree burns that cover more than 30% of TBSA 2. 3rd degree burns that cover more than 10% of TBSA |
4. Information |
KeraHeal® is a spray-type autologous keratinocyte therapy product that has received product approval in 2006 by the MFDS. Keratinocytes are separated and cultured from the patient’s normal skin, which then form a new epidermal layer on the wound through engraftment and duplication. KeraHeal® is composed of keratinocytes that cultivate, but do not differentiate which in turn shows a high take rate. |
5. Images |
|
Pharmaceutical Product Information |
|
1. Brand Name |
KeraHeal-Allo™ |
2. Active Ingredient |
Allogeneic skin-derived keratinocytes |
3. Indication |
Deep second degree burns |
4. Information |
KeraHeal-Allo™ is a hydrogel-type allogeneic keratinocyte therapy product that has received product approval in 2015 by the MFDS. KeraHeal-Allo™ is composed of allogeneic keratinocytes that promote re-epithelialization by secreting growth factors and cytokines to stimulate the cells around the wound. Keratinocytes are suspended in a thermosensitive hydrogel which transforms into gel from liquid when in contact with body temperature. KeraHeal-Allo™ can be stored at –20℃ for up to 18 months. |
5. Images |
|
Division
Written by 한지혜